摘要:
The compounds of the present invention relates to tetrahydropyridine derivatives and have high affinity and specificity to σ receptors, whereby these are thought to be effective for some psychoses.
摘要:
Compounds of the formula: (wherein R is phenoxy optionally substituted by a halogen, methoxy, or methyl group, one of A and B is and the other is R 1 is hydrogen or C 1 -C 5 alkyl;
Z 1 is phenyl, benzyl. or isoxazolyl each optionally substituted by a halogen, methoxy, or methyl group; Z 2 is hydrogen, C 1 -C 5 alkyl, C 2 -C 5 alkenyl, or phenyl optionally mono-, di-, or tri-substituted by a halogen, methoxy, or methyl group; or Z 1 and Z 2 taken together with the adjacent nitrogen atom may form 5-membered heterocyclic group: Z 3 is Ci-C 5 hydroxyalkyl, di(C 1 -C 5 alkyl)sulfamoyl, 6-membered heterocyclic group, phenyl, benzyl, or phenylsulfonyl each phenyl moiety of the last three members being optionally substituted by a halogen, methoxy, or methyl group: Z 4 is phenyl optionally substituted by a halogen, methoxy, or methyl group or 5- or 6-membered heterocyclic group which is optionally substituted by a halogen, methoxy, or methyl group and which can be optionally condensed with a benzene ring; Z 5 is thienyl or phenyl each optionally substituted by a halogen, methoxy, or methyl group; Z 6 is thienyl or phenyl each optionally substituted by a halogen, methoxy, or methyl group; m is an integer from 0 to 2; n is an integer from 2 to 3), and their acid addition salts may be useful as drugs for senile dementia, or as psychotropic, or antiamnesia agents.
摘要翻译:下式的化合物:其中R是任选被卤素,甲氧基或甲基取代的苯氧基,A和B之一的CHEM是CHEM,另一个是CHEM R 1是氢 或C 1 -C 5烷基; Z 1是各自任选被卤素,甲氧基或甲基取代的苯基,苄基或异恶唑基; Z 2是氢,C 1 -C 5烷基,C 2 -C 5烯基或任选的苯基 被卤素,甲氧基或甲基单取代,二取代或三取代;或与相邻氮原子一起使用的Z 1和Z 2可以形成5元杂环基; Z 3为 C1-C5羟基烷基,二(C1-C5烷基)氨磺酰基,6元杂环基,苯基,苄基或苯基磺酰基,最后三个成员的每个苯基部分任选被卤素,甲氧基或甲基取代; Z 4 是任选被卤素,甲氧基或甲基取代的苯基或任选被卤素,甲氧基或甲基取代的5-或6-元杂环基,其可以是任选的 与苯环稠合; Z 5是噻吩基或各自任选被卤素,甲氧基或甲基取代的苯基; Z 6是任选被卤素,甲氧基或甲基取代的噻吩基或苯基; m为0〜2的整数; n为2至3的整数),并且它们的酸加成盐可用作老年痴呆的药物,或作为精神药物或抗遗忘因子。
摘要:
The compounds of the present invention relates to tetrahydropyridine derivatives and have high affinity and specificity to σ receptors, whereby these are thought to be effective for some psychoses.